UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 861177 NEW YORK, NY

Back to VIR Full portfolio

Position in VIR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,169,306

+$439,196 QoQ

Shares Held

130,503

+7.8% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

24 quarters on record

Voting authority Sole 48% Shared 0% None 52%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,811 across 211 Biotechnology names. VIR ranks #123 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,057,396	$1,365,249,602
2	REGN	Regeneron Pharmaceuticals, Inc.	723,621	$559,098,523
3	ALNY	Alnylam Pharmaceuticals, Inc.	677,519	$224,170,706
4	INSM	INSMED Inc	1,215,025	$198,680,883
5	RPRX	Royalty Pharma plc	3,095,766	$148,503,890
6	INCY	Incyte Corp	1,540,913	$145,030,725
7	IONS	Ionis Pharmaceuticals Inc	1,475,632	$110,805,201
8	DNLI	Denali Therapeutics Inc.	4,432,314	$85,100,425

All Filings in VIR

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,169,306	130,503	+7.8%	Shares	Defined	2026-05-13
2025-12-31	$730,110	121,080	-15.9%	Shares	Defined	2026-02-13
2025-09-30	$821,884	143,938	-51.1%	Shares	Sole	2025-11-14
2025-06-30	$1,483,685	294,383	+47.9%	Shares	Defined	2025-08-14
2025-03-31	$1,289,924	199,063	+9.8%	Shares	Defined	2025-05-19
2024-12-31	$1,330,922	181,325	+29.2%	Shares	Defined	2025-02-14
2024-09-30	$1,051,377	140,371	-17.7%	Shares	Defined	2024-11-14
2024-06-30	$1,517,972	170,559	+85.3%	Shares	Defined	2024-08-14
2024-03-31	$932,556	92,059	0.0%	Shares	Sole	2024-05-15
2023-12-31	$926,111	92,059	+14.5%	Shares	Sole	2024-02-14
2023-09-30	$753,478	80,414	-9.9%	Shares	Sole	2023-11-13
2023-06-30	$2,189,129	89,243	0.0%	Shares	Sole	2023-08-11
2023-03-31	$2,076,682	89,243	+24.4%	Shares	Sole	2023-05-15
2022-12-31	$1,815,864	71,745	+13.5%	Shares	Sole	2023-02-14
2022-09-30	$1,219,091	63,231	-19.5%	Shares	Sole	2022-11-14
2022-06-30	$2,001,074	78,566	+16.4%	Shares	Defined	2022-08-12
2022-03-31	$1,735,584	67,480	+3.7%	Shares	Defined	2022-05-16
2021-12-31	$2,723,306	65,042	+2.1%	Shares	Defined	2022-02-14
2021-09-30	$2,773,050	63,719	+0.9%	Shares	Defined	2021-11-15
2021-06-30	$2,986,677	63,170	+528.0%	Shares	Defined	2021-08-16
2021-03-31	$515,724	10,059	0.0%	Shares	Defined	2021-05-14
2020-12-31	$269,380	10,059	-92.2%	Shares	Defined	2021-03-01
2020-09-30	$4,403,096	128,258	-14.4%	Shares	Defined	2020-11-13
2020-06-30	$6,139,640	149,857	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.